(Q46938051)

English

Liquid chromatography/tandem mass spectrometry characterization of oxidized amyloid beta peptides as potential biomarkers of Alzheimer's disease.

scientific article published in January 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Liquid chromatography/tandem mass spectrometry characterization of oxidized amyloid beta peptides as potential biomarkers of Alzheimer's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Koichi Inoue

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Carlos Garner

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Bradley L Ackermann

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Ian A Blair

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Rapid Communications in Mass Spectrometry

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

911-918

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Amyloid, the presenilins and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Possible mechanisms of APP-mediated oxidative stress in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

The metallobiology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Redox-active metals, oxidative stress, and Alzheimer's disease pathology

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught?

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Therapeutic strategies for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

CSF biomarkers for mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

CSF biomarkers for mild cognitive impairment and early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Development of a specific ELISA for the quantitative study of amino-terminally truncated beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same?

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Concentrations of amyloid beta protein in cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Low cerebrospinal-fluid concentrations of soluble amyloid beta-protein precursor in hereditary Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Age-dependent change in the levels of Abeta40 and Abeta42 in cerebrospinal fluid from control subjects, and a decrease in the ratio of Abeta42 to Abeta40 level in cerebrospinal fluid from Alzheimer's disease patients.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Cerebrospinal fluid amyloid beta(1-42) levels in the mild cognitive impairment stage of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Quantification of the A beta peptide in Alzheimer's plaques by laser dissection microscopy combined with mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Contact regions in the dimer of Alzheimer beta-amyloid domain [1-28] studied by mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Abeta peptide

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Human cerebrospinal fluid peptidomics

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Possible involvement of copper(II) in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Oxidative stress and redox-active iron in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Cu(II)-catalyzed oxidation of beta-amyloid peptide targets His13 and His14 over His6: Detection of 2-Oxo-histidine by HPLC-MS/MS.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Selective Cu2+/ascorbate-dependent oxidation of alzheimer's disease beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Products of Cu(II)-catalyzed oxidation in the presence of hydrogen peroxide of the 1-10, 1-16 fragments of human and mouse beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Development of a methodology based on metal-catalyzed oxidation reactions and mass spectrometry to determine the metal binding sites in copper metalloproteins

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Using mass spectrometry to study copper-protein binding under native and non-native conditions: beta-2-microglobulin

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Rapid characterization of amyloid-beta side-chain oxidation by tandem mass spectrometry and the scoring algorithm for spectral analysis

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Cu(II) interaction with N-terminal fragments of human and mouse beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Coordination abilities of the 1-16 and 1-28 fragments of beta-amyloid peptide towards copper(II) ions: a combined potentiometric and spectroscopic study

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

The antioxidant effect of tannic acid on the in vitro copper-mediated formation of free radicals

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Ascorbate compartmentalization in the CNS.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction†

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Identifiers

10.1002/RCM.2395

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46938051&oldid=2145814291"